CORC

浏览/检索结果: 共4条,第1-4条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:45/0  |  提交时间:2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
The development of pediatric peritoneal dialysis in China: Brief data report from IPPN China 会议论文
作者:  Zhai, Y.;  Xu, H.;  Yang, Q.;  Dang, X.;  Sun, S.
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/19
The effect of SCN1A, SCN2A, ABCC2, and UGT2B7 genetic polymorphisms on oxcarbazepine dose requirements in Chinese Han patients with epilepsy. 会议论文
作者:  Ma, Chun-Lai;  Wu, Xun-Yi;  Jiao, Zheng;  Zhong, Ming-Kang
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/19


©版权所有 ©2017 CSpace - Powered by CSpace